SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-12G/A - Registration of securities [Section 12(g)][Amend]
SEC Accession No. 0001019687-14-003749
Filing Date
2014-10-01
Accepted
2014-10-01 17:13:41
Documents
7
Filing Date Changed
2014-10-01

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #2 vg_1012ga2.htm 10-12G/A 1981701
2 CONVERTIBLE PROMISSORY NOTE vg_ex10-133.htm EX-10.133 144165
3 AMENDMENT TO REGISTRATION RIGHTS AGREEMENT vg_ex10-134.htm EX-10.134 6513
4 CONVERTIBLE PROMISSORY NOTE vg_ex10-135.htm EX-10.135 47177
5 WARRANT vg_ex10-136.htm EX-10.136 37766
6 CONVERTIBLE PROMISSORY NOTE vg_ex10-137.htm EX-10.137 47181
7 WARRANT vg_ex10-138.htm EX-10.138 38495
  Complete submission text file 0001019687-14-003749.txt   2304165
Mailing Address 121 GRAY AVENUE, SUITE 200 SANTA BARBARA CA 93101
Business Address 121 GRAY AVENUE, SUITE 200 SANTA BARBARA CA 93101 805-879-9000
VG Life Sciences, Inc. (Filer) CIK: 0001091326 (see all company filings)

IRS No.: 330814123 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-12G/A | Act: 34 | File No.: 000-26875 | Film No.: 141133873
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1